Harborside


RIV Capital Inc.

TSE: RIV


Canadian symbol: RIV.TO
US symbol: CNPOF

Currency in CAD

Valuation Measures

Market Cap (intraday) 5269.2M
Enterprise Value 3141.74M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)20.04
Price/Book (mrq)0.86
Enterprise Value/Revenue 310.55
Enterprise Value/EBITDA 7-2.30

Trading Information

Stock Price History

Beta (5Y Monthly) 1.88
52-Week Change 385.29%
S&P500 52-Week Change 336.19%
52 Week High 33.6000
52 Week Low 30.6500
50-Day Moving Average 31.8691
200-Day Moving Average 32.2001

Share Statistics

Avg Vol (3 month) 3201.74k
Avg Vol (10 day) 3133.58k
Shares Outstanding 5142.44M
Implied Shares Outstanding 6191.5M
Float 108.17M
% Held by Insiders 13.64%
% Held by Institutions 139.19%
Shares Short (Jul. 14, 2021) 4100.07k
Short Ratio (Jul. 14, 2021) 40.55
Short % of Float (Jul. 14, 2021) 4N/A
Short % of Shares Outstanding (Jul. 14, 2021) 40.07%
Shares Short (prior month Jun. 14, 2021) 464.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar. 30, 2021
Most Recent Quarter (mrq)Mar. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-458.60%

Management Effectiveness

Return on Assets (ttm)-12.11%
Return on Equity (ttm)-43.91%

Income Statement

Revenue (ttm)13.43M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-70.50%
Gross Profit (ttm)-40.23M
EBITDA -61.56M
Net Income Avi to Common (ttm)-133.88M
Diluted EPS (ttm)-0.7200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)127.88M
Total Cash Per Share (mrq)0.9
Total Debt (mrq)420k
Total Debt/Equity (mrq)0.14
Current Ratio (mrq)5.57
Book Value Per Share (mrq)2.19

Cash Flow Statement

Operating Cash Flow (ttm)-8.09M
Levered Free Cash Flow (ttm)-8.56M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
RIV.TO
RIV Capital
3 weeks ago
RIV.TO
RIV Capital
5 months ago
RIV.TO
RIV Capital
5 months ago
RIV.TO
RIV Capital
5 months ago
RIV.TO
RIV Capital
5 months ago
RIV.TO
RIV Capital
5 months ago
RIV.TO
RIV Capital
7 months ago
RIV.TO
RIV Capital
7 months ago
RIV.TO
RIV Capital
7 months ago
RIV.TO
RIV Capital
8 months ago
RIV.TO
RIV Capital
10 months ago
RIV.TO
RIV Capital
10 months ago
RIV.TO
RIV Capital
10 months ago
RIV.TO
RIV Capital
11 months ago
RIV.TO
RIV Capital
11 months ago
RIV.TO
RIV Capital
11 months ago
RIV.TO
RIV Capital
11 months ago
RIV.TO
RIV Capital
11 months ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
1 year ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago
RIV.TO
RIV Capital
2 years ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2021)Next Year (2022)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS-0.01-0.1N/AN/A
Revenue EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2021)Next Year (2022)
No. of Analysts1111
Avg. Estimate5.02MN/AN/A3.62M
Low Estimate5.02M1.4M1.28M3.62M
High Estimate5.02M1.4M1.28M3.62M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2019-12-302020-03-302020-06-292020-09-29
EPS Est.-0.01-0.02-0.01-0.01
EPS Actual-0.01-0.1-0.02-0.15
Difference0-0.08-0.01-0.14
Surprise %0.00%-400.00%-100.00%-1,400.00%
EPS TrendCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2021)Next Year (2022)
Current Estimate0000
7 Days Ago-0.09-0.0200
30 Days Ago-0.09-0.0200
60 Days Ago-0.09-0.0200
90 Days Ago-0.09-0.0200
EPS RevisionsCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRIV.TOIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
3.64%% of Shares Held by All Insider
39.19%% of Shares Held by Institutions
40.67%% of Float Held by Institutions
14Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
AdvisorShares Investments, LLC7,310,606Mar. 30, 20215.13%17,033,711
Tocqueville Asset Management L.p.70,400Mar. 30, 20210.05%164,032
Fishman (Jay A.), Ltd.20,000Mar. 30, 20210.01%46,600

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF5,584,829Jun. 29, 20213.92%11,783,989
Global X Fds-The Global X Cannabis ETF4,734,713Jun. 29, 20213.32%9,990,244
Spinnaker ETF Tr-Cannabis ETF3,615,343Feb. 27, 20212.54%10,954,489
Amplify Seymour Cannabis ETF3,167,910Jun. 29, 20212.22%6,684,290
AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF2,056,303Jun. 29, 20211.44%4,338,799
Cambria ETF Tr-Cambria Cannabis ETF903,599Jun. 29, 20210.63%1,906,593
Investment Managers Ser Tr II-Cannabis Growth Fd55,000Apr. 29, 20210.04%125,950
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by RIV Capital Inc.


RIV Capital Portfolio Company ZeaKal Unveils Breakthrough High-Oil Hemp Results

RIV Capital Portfolio Company ZeaKal Unveils Breakthrough High-Oil Hemp Results

ZeaKal's novel PhotoSeed trait boosts hemp biomass oil output by up to 50% TORONTO and SAN DIEGO, June 1, 2021 - RIV Capital Inc. ("RIV Capital") (TSX: RIV) (OTC: CNPOF) portfolio company ZeaKal, Inc. ("ZeaKal") announced that its PhotoSeed™ technology is believed to be the first plant trait proven to enhance the oil profile of hemp, offe... Read More...
Canopy Rivers Reports Third Quarter Fiscal Year 2021 Financial Results

Canopy Rivers Reports Third Quarter Fiscal Year 2021 Financial Results

Comprehensive income of $82.2 million driven by significant increase in value of investment in TerrAscend Announced transformative and accretive transaction with Canopy Growth, expected to close by the end of February Anticipates being in strong financial and strategic position to pivot to the U.S. market following the closing of CGC Tran... Read More...
Canopy Rivers Sets Filing Date For Q3 Fiscal Year 2021 Financial Results

Canopy Rivers Sets Filing Date For Q3 Fiscal Year 2021 Financial Results

TORONTO, Jan. 27, 2021 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will report its third quarter fiscal year 2021 financial results before markets open on February 10, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial ... Read More...
Canopy Rivers Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

Canopy Rivers Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

TORONTO, Jan. 20, 2021 - Canopy Rivers Inc. ("Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) today filed and mailed the management information circular (the "Circular") and related materials in connection with the special meeting (the "Meeting") of shareholders to be held virtually on February 16, 2021 at 10:00 a.m. (Toronto time). In ... Read More...
Canopy Rivers to Monetize Certain Portfolio Assets for Total Transaction Value of Approximately $297 Million and Eliminate Dual Class Share Structure Pursuant to Agreement with Canopy Growth, Allowing Canopy Rivers to Shift Strategic Focus to Explore New Cannabis Markets Following Closing

Canopy Rivers to Monetize Certain Portfolio Assets for Total Transaction Value of Approximately $297 Million and Eliminate Dual Class Share Structure Pursuant to Agreement with Canopy Growth, Allowing Canopy Rivers to Shift Strategic Focus to Explore New Cannabis Markets Following Closing

Rivers to sell its interests in TerrAscend, Tweed Tree Lot, and Vert Mirabel to Canopy Growth at implied total transaction value of approximately $297 million, representing an aggregate ROIC of approximately 5.6x and IRR of approximately 101% Rivers to receive $115 million in cash and 3,750,000 common shares of Canopy Growth and cancel al... Read More...
Canopy Rivers Provides Update on PharmHouse Sale and Investment Solicitation Process, Debtor-in-Possession Financing

Canopy Rivers Provides Update on PharmHouse Sale and Investment Solicitation Process, Debtor-in-Possession Financing

TORONTO, Dec. 18, 2020 - Canopy Rivers Inc. ("Canopy Rivers'' or the "Company") (TSX: RIV) (OTC: CNPOF) today provided an update on its 49%-owned joint venture, PharmHouse Inc. ("PharmHouse"). On October 29, 2020, PharmHouse received a court order from the Ontario Superior Court of Justice (the "Court") to initiate a sale and investment ... Read More...
Canopy Rivers reports second quarter fiscal year 2021 financial results

Canopy Rivers reports second quarter fiscal year 2021 financial results

Aggregate charges of $112.3 million recognized on PharmHouse investments Appreciation of 101% in TerrAscend share price – current implied TerrAscend investment value of $214.5 million1 Continued growth and expansion within portfolio TORONTO, Nov. 9, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) today... Read More...
Canopy Rivers Sets Filing Date for Q2 Fiscal Year 2021 Financial Results

Canopy Rivers Sets Filing Date for Q2 Fiscal Year 2021 Financial Results

TORONTO, Nov. 2, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will report its second quarter fiscal year 2021 financial results before markets open on November 9, 2020. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial r... Read More...
Canopy Rivers Announces Results of Annual General and Special Meeting of Shareholders

Canopy Rivers Announces Results of Annual General and Special Meeting of Shareholders

Asha Daniere appointed Chair, Constellation Brands' CFO Garth Hankinson elected to Board of Directors TORONTO, Sept. 24, 2020 - Canopy Rivers Inc. (the "Company") (TSX: RIV) (OTC: CNPOF) announced the voting results of its annual general and special meeting of shareholders (the "Meeting") held today. In total, 59,090,152 of the Company's... Read More...
PharmHouse Pursues Formal Restructuring

PharmHouse Pursues Formal Restructuring

Joint venture seeks creditor protection while it restructures its business, financial obligations Canopy Rivers to provide up to $7.2 million in interim DIP financing TORONTO, Sept. 16, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) announces that PharmHouse Inc. ("PharmHouse"), the Company's 49%-owne... Read More...
Canopy Rivers Announces Receipt of Statement of Claim in Respect of Pharmhouse Joint Venture

Canopy Rivers Announces Receipt of Statement of Claim in Respect of Pharmhouse Joint Venture

TORONTO, Sept. 14, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") announced that it has received a statement of claim (the "Claim") filed by 2615975 Ontario Inc., the Company's joint venture partner in PharmHouse Inc. ("PharmHouse"), concerning certain disputes relating to PharmHouse. The Claim makes a number of allegations ... Read More...
Canopy Rivers Announces AGM Date

Canopy Rivers Announces AGM Date

TORONTO, Aug. 18, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will hold its annual general and special meeting (the "Meeting") of shareholders of the Company ("Shareholders") on September 24, 2020 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Compan... Read More...
Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results

Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results

Formed Special Committee to oversee investment in PharmHouse Enhanced strategic exposure to cannabis 2.0 through investment in Dynaleo Achieved significant progress toward operating expense reduction targets Well-positioned for U.S. market development through key successes at TerrAscend TORONTO, Aug. 14, 2020 - Canopy Rivers Inc. (the "Co... Read More...
Canopy Rivers Portfolio Companies Look to Expand Retail and Brand Presence in North American Markets

Canopy Rivers Portfolio Companies Look to Expand Retail and Brand Presence in North American Markets

Company provides update on Dynaleo, Agripharm, and TerrAscend TORONTO, July 10, 2020 - Three of Canopy Rivers Inc.'s ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) portfolio companies have made recent announcements as they aim to introduce new or expanded choices for cannabis consumers and medical patients in Canada and the U.S. "We continue t... Read More...
Deep Space Cannabis Beverage Has Launched

Deep Space Cannabis Beverage Has Launched

18H 36M 56.3364S, 38o 47' 01.291SMITHS FALLS, ON , June 16, 2020 - Deep Space, a full-flavoured cannabis beverage with 10 mg THC in a 222 mL aluminum vessel, has launched.Canopy Growth Logo (CNW Group/Canopy Growth Corporation)Deep Space is available for purchase on provincial ecommerce platforms and select cannabis retailers including Tw... Read More...
Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights

Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights

Strong financial position with $47 million cash on hand and no debt Commenced operational ramp-up at 1.3 million sq.ft. flagship joint venture Expanded ag-tech exposure in portfolio Significant corporate milestones, including graduation to the TSX and launch of Strategic Advisory Board TORONTO, June 3, 2020 - Canopy Rivers Inc. (the "Comp... Read More...
Canopy Rivers Updates Date for Reporting Fourth Quarter and Fiscal Year 2020 Financial Results

Canopy Rivers Updates Date for Reporting Fourth Quarter and Fiscal Year 2020 Financial Results

TORONTO, May 26, 2020 - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets open on Wednesday, June 3, 2020. The Company's audited consolidated financial statements and management's discussion and analysis ... Read More...
Canopy Rivers to Report Fourth Quarter and Fiscal Year 2020 Financial Results

Canopy Rivers to Report Fourth Quarter and Fiscal Year 2020 Financial Results

TORONTO, May 11, 2020 - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets open on Friday, May 29, 2020. The Company's audited consolidated financial statements and management's discussion and analysis for... Read More...
Canopy Rivers' Flagship Joint Venture PharmHouse Increases Bank Debt Facility by $10 Million

Canopy Rivers’ Flagship Joint Venture PharmHouse Increases Bank Debt Facility by $10 Million

TORONTO , April 16, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario , amended its syndicated credit facility ("Credit Facility") with the Bank of Montreal ("BMO"), as the agent and lead lender, and th... Read More...
Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth

Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth

Loan expected to provide TerrAscend Canada with additional capital to fund Canadian operations, U.S. hemp division, international expansion, and repayment of debt TORONTO, March 11, 2020 - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company, TerrAscend Corp. ("TerrAscend") (CSE: TER,OTCQX: TRSSF), today announced... Read More...
Canopy Rivers' Pharmhouse Joint Venture Receives Milestone Licence Amendment

Canopy Rivers’ Pharmhouse Joint Venture Receives Milestone Licence Amendment

1.3 million sq. ft. automated facility now fully licensed TORONTO, March 2, 2020 - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario, received a licence amendment from Health Canada allowing for cultivation across its entire g... Read More...
Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

TORONTO, Feb. 14, 2020 - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and nine months ended December 31, 2019 ("Q3 2020"). The Company's unaudited condensed interim consolidated financial statements for Q3 2... Read More...
Canopy Rivers Files Early Warning Report in Connection with James E. Wagner Cultivation Investment

Canopy Rivers Files Early Warning Report in Connection with James E. Wagner Cultivation Investment

TORONTO, Feb. 7, 2020 - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that Canopy Rivers Corporation ("Canopy Rivers") subscribed for 2,380,952 units (each a "Unit") of James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) at a price of $0.21 per Unit for... Read More...
Canopy Rivers' CEO Added to NCIA Board, Portfolio Companies Grow North American Footprint

Canopy Rivers’ CEO Added to NCIA Board, Portfolio Companies Grow North American Footprint

Canopy Rivers provides update on High Beauty, TerrAscend, Canapar, and JWC TORONTO, Feb. 6, 2020 - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and its portfolio companies have made a series of recent announcements that include a board appointment for Canopy Rivers' Presiden... Read More...
Canopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

Canopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

TORONTO, Jan. 24, 2020 - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its third quarter fiscal year 2020 financial results before markets open on Friday, February 14, 2020. The Company's unaudited condensed interim consolidated financial statemen... Read More...
Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations

Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations

Canopy Rivers provides update on High Beauty, TerrAscend, YSS, and JWCTORONTO , Jan. 17, 2020 - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies have made a series of recent announcements relating to their plans for the cannabis retail market or U.S. cannabis... Read More...
Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

BioLumic partners with JWC and Helius Therapeutics for cannabis research program TORONTO, Jan. 8, 2020 - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply its proprietary ultraviolet ("UV") light technology to medi... Read More...
Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board

Kevin Durant’s Thirty Five Ventures Joins Canopy Rivers’ Strategic Advisory Board

Advisory board role marks star-backed venture firm's first exposure to Canadian cannabis sector TORONTO, Nov. 26, 2019 - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, has further bolstered its Strategic Advisory Board ("Advisory Board"), adding Thirty Five Ventures, the busin... Read More...
Canopy Rivers Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

Canopy Rivers Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

TORONTO, Nov. 14, 2019 - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and six months ended September 30, 2019 ("Q2 2020"). The Company's unaudited condensed interim consolidated financial statements for Q2 2... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
RIV.TO
The Toronto Stock Exchange
The Toronto Stock Exchange1.89CAD0.00%
CNPOF.PK
US 'Other OTC' and Grey Market
US 'Other OTC' and Grey Market1.52USD-1.30%
RIV.GO
Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities
Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities1.92CAD0.00%
CNPOF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L21.51USD-1.95%
RIV.ALP
Alpha - Canadian ATS
Alpha - Canadian ATS1.91CAD-0.52%

Delayed data (1h)


Share this page